Gain an Insight into the Different Sectors within the Stem Cells Industry.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c47803) has announced the addition of Stem Cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. Markets to their offering. The purpose of this report is to describe the specific market segments of the medical research space using stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young for research and development (R&D) purposes. This study reviews all of the generally accepted analytical analytical, analytic pertaining to or emanating from analysis. analytical control control of confounding by analysis of the results of a trial or test. methods that are currently in use today for preparing and using stem cells. It examines the use of stem cells in developing new therapies for disease. The main objectives of this analysis are: * Identifying viable technology drivers through a comprehensive look at platform technologies for stem cells. * Understanding the different sectors of stem cells, such as embryonic em·bry·on·ic or em·bry·on·al adj. Of, relating to, or being an embryo. Embryonic In the life cycle of the round worm, a very early life stage occurring within the uterus of the female round worm. , adult and cord blood cord blood n. Blood present in the umbilical vessels at the time of delivery. . * Obtaining a complete understanding of the individual stem cells platforms from their basic principles to their clinical applications. * Discovering feasible (algorithm) feasible - A description of an algorithm that takes polynomial time (that is, for a problem set of size N, the resources required to solve the problem can be expressed as some polynomial involving N). market opportunities by identifying high-growth applications in different stem cell areas. * Focusing on global industry development through an in-depth in-depth adj. Detailed; thorough: an in-depth study. in-depth Adjective detailed or thorough: an in-depth analysis analysis of the major world markets for stem cell technology, including growth forecasts. * Present market figures regarding the current value of stem cells, market projections, market share, key players, and sector growth rates Growth Rates The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures. Notes: Remember, historically high growth rates don't always mean a high rate of growth looking into the future. .
Topics Covered
1. Overview
1.1 Statement of Report
1.2 Scope of the Report
1.3 Methodology
1.4 Executive Summary
2. Biology of Stem Cells
2.1 Scope of this Chapter
2.2 Basic Properties of Stem Cells and Their Classification
2.3 Differentiation of Stem Cells
2.3.1 Neural and Neuronal Differentiation
2.3.2 Cardiomyogenic Differentiation of ESCs
2.3.3 Differentiation of Mesenchymal Stem/Progenitor Cells
2.4 Self Renewal of Stem Cells
2.5 Dedifferentiation and Nuclear Reprogramming
2.6 Functional Proliferation of Adult Mature Cells
2.7 Nanog Promotes Transfer of Pluripotency after Cell Fusion
2.8 MicroRNAs in Stem Cell Development
2.9 Stem Cell Therapy
3. Market Analysis of the Stem Cells Space
3.1 Scope of this Chapter
3.2 The Overall Market Opportunity and Segmentation of the Total Stem
Cells Marketplace
3.3 Potential Stem Cell Commercial Applications
3.3.1 Cord Blood Stem Cells and Cord Blood Stem Cell Banking: Current
Market Environment and Opportunity
3.4 Results of Primary Market Survey to Characterize Qualitative and
Quantitative Trends in the Stem Cells Space
3.4.1 Characteristics of the Respondent Pool
3.4.2 Utilization of the Different Classes of Stem Cells
3.4.3 Quantitative Metrics of the Stem Cell Research Marketplace:
Number of Experiments Performed, Research
3.4.4 Evolution of Research Activities with the Different Types of
Stem Cells: Current Usage Trends and Usage in 12 to 18 Months
3.4.5 Types of Research Activities the End-User Community Performing
with the Different Types of Stem Cells
3.4.6 Challenges Facing Stem Cell Researchers
3.4.7 Market Drivers and Research Questions Being Addressed in the
Stem Cells Space
3.4.8 Summary of Challenges and Opportunities in the Stem Cells Space
Based on TriMark's Analysis
3.4.9 Unmet Product Needs in the Stem Cells Research Space and
Licensing/IP Constraints
3.5 Competitive Landscape of the Stem Cells Marketplace
3.5.1 SWOT Analysis of the Major Stem Cell Market Segments
3.6 Market Size and Forecasts
4. Worldwide Landscape of Stem Cell Research
4.1 Scope of this Chapter
4.2 Global Embryonic Stem Cell Research
4.2.1 Top Research Institutions Worldwide in the Stem Cells Space and
Global "Hot Spots" for Research and Therapeutics
4.3 Stem Cell Research in the U.S.
4.3.1 Proposition 71 in the State of California
4.4 Intellectual Property (IP) Landscape Surrounding Stem Cells
4.5 Who Will Finance Stem Cell Research?
4.5.1 U.S. Government Policy on Stem Cell Research
4.5.2 Current Federal Policy
4.5.2.1 Moral Issues Affecting the Policy
4.5.2.2 Significance and Requirement of Federal Funding
4.5.2.3 Implementing the Current Policy
4.5.3 International Law
4.5.3.1 Australia
4.5.3.2 U.K.
4.5.3.3 Canada
4.5.3.4 China
4.5.3.5 Germany
4.5.3.6 Switzerland
4.5.3.7 Japan
4.5.3.8 Israel
4.5.3.9 Singapore
4.5.4 Technological and Economical Disadvantage for U.S.
5. Therapeutic Areas and Research Programs in the Stem Cells Space
5.1 Scope of this Chapter
5.2 Therapeutic and Other Markets Addressed by Stem Cells
5.2.1 Hematopoietic Stem Cells (HSCs)
5.2.2 Stem Cell Therapeutics for Cardiac and Ischemic Diseases
5.2.3 Stem Cell Therapeutics for Type I Diabetes
5.2.4 Stem Cell Therapeutics for Orthopedic Diseases
5.2.5 Stem Cell Therapeutics for Neurological Disease
5.3 Off-the-Shelf Stem Cells Being Developed
6. Company Profiles 85
Appendix 1. Glossary of Terms in Stem Cell Biology
INDEX OF FIGURES
INDEX OF TABLES
For more information visit http://www.researchandmarkets.com/reports/c47803 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion